LYKALABSNSELyka Labs Limited· PharmaceuticalsLowNeutral
Announced Thu, 26 Jun · 21:31 IST

Lyka Labs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The promoters and persons acting in concert (PAC) of Lyka Labs Limited have filed a Regulation 31(4) disclosure with the stock exchanges for FY 2024-25. Under this SEBI regulation, promoters declare that they have not created any new encumbrances (such as pledges or liens) on their shares during the financial year, other than those already disclosed earlier. The named promoters and PAC include Kunal Narendra Gandhi, Alisha Kunal Gandhi, Nehal Narendra Gandhi, Lyka Generics Limited, Enai Trading and Investment Pvt. Limited, and Hiralaxmi Multitrade Pvt. Limited. This is a routine annual compliance filing required by SEBI takeover regulations.

Likely market impact

This is a routine compliance filing and is generally neutral for shareholders. The confirmation of no new encumbrances is mildly reassuring, indicating promoters have not added new pledges or liens on their holdings during the year.